Summary
Recombinant murine (rMu) tumor necrosis factor (TNF), in a standard comitogenic assay with phytohemagglutinin, induced murine thymocyte proliferation, while up to 10,000-fold higher concentrations of recombinant human TNF did not. The induction of thymocyte proliferation was dependent upon TNF concentration in a biphasic manner. Thus, 100 to 1000 units/ml TNF were near optimal while concentrations ≥1,000 units/ml caused apparent down regulation. The effect was abrogated by neutralizing antibody to rMu-TNF but not by neutralizing antibody to rMu-interleukin 1α or β. The rMu-TNF did not induce proliferation of the mature murine T-helper cell line, D10.G4.1, in the presence of mitogen. Taken together the results indicate that TNF, in a strictly species-specific manner, can regulate thymocyte proliferation independently of interleukin 1.
Similar content being viewed by others
References
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666–3670
Elias JA, Gustilo K, Baeder W, Freundlich B (1987) Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol 138:3812–3816
Fransen L, Ruysschaert MR, Van Der Heyden J, Fiers W (1986) Recombinant tumor necrosis factor: Species specificity for a variety of human and murine transformed cell lines. Cell Immunol 100:260–267
Hori K, Ehrke MJ, Mace K, Mihich E (1987) Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: Synergism between tumor necrosis factor and γ-interferon. Cancer Res 47:5868–5874
Huang JJ, Newton RC, Rutledge SJ, Horuk R, Matthew JB, Covington M, Lin Y (1988) Characterization of murine IL-1β, isolation, expression and purification. J Immunol 140:3838–3843
Jelinek DF, Lipsky PE (1987) Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-α and interleukin 1. J Immunol 139:2970–2976
Kaye J, Janeway CA Jr (1984) Induction of receptors for IL-2 requires T cell Ag:Ia receptor crosslinking and interleukin 1. Lymphokine Res 3:175–181
Kohase M, Henrikson-DeStefano D, May LT, Vilcek J, Sehgal PB (1986) Induction of beta-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation. Cell 45:659–666
Kramer SM, Aggarwal BB, Eessalu TE, McCabe SM, Ferraiolo BL, Figari IS, Palladino MA Jr (1988) Characterization of the in vivo and in vitro species preference of human and murine tumor necrosis factor-α. Cancer Res 48:920–925
Lachman LB, Brown DC, Dinarello CA (1987) Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. J Immunol 138:2913–2916
Le J, Vilcek J (1987) Biology of disease. Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab Invest 56:234–248
Mace K, Mayhew E, Mihich E, Ehrke MJ (1988) Alterations in murine host defense functions by Adriamycin or liposome-encapsulated Adriamycin. Cancer Res 48:130–136
March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosman D (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641–647
Matsushima K, Akahoshi T, Yamada M, Furutani Y, Oppenheim JJ (1986) Properties of a specific interleukin 1 (IL1) receptor on human Epstein-Barr virus-transformed B lymphocytes: Identity of the receptor for IL1-α and IL1-β. J Immunol 136:4496–4502
Mizel SB, Dukovich M, Rothstein J (1983) Preparation of goat antibodies against interleukin 1: Use of an immunoadsorbent to purify interleukin 1. J Immunol 131:1834–1837
Old LJ (1985) Tumor necrosis factor (TNF). Science 230:630–632
Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA (1986) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137:1893–1896
Ranges GE, Figari IS, Espevik T, Palladino MA Jr (1987) Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J Exp Med 166:991–998
Scheurich P, Thoma B, Ucer U, Pfizenmaier K (1987) Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-α: Induction of TNF receptors on human T cells and TNF-α-mediated enhancement of T cell responses. J Immunol 138:1786–1790
Shirai T, Yamaguchi Y, Ito H, Todd DW, Wallace RB (1985) Cloning and expression in E. coli of the gene for human tumor necrosis factor. Nature 313:803–806
Smith RA, Kirstein M, Fiers W, Baglioni C (1986) Species specificity of human and murine tumor necrosis factor. J Biol Chem 261:14871–14874
Stewart WE II (1984) Heterogeneities of human interferons. In: Mihich E (ed) Biological responses in cancer: progress toward potential applications. Plenum Press, New York, pp 19–44
Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM (1985) Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro. Science 230:943–945
Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH (1988) B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 140:508–512
Yokota S, Geppert TD, Lipsky PE (1988) Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α. J Immunol 140:531–536
Zucali JR, Elfenbein GJ, Barth KC, Dinarello CA (1987) Effects of human interleukin 1 and human tumor necrosis factor on human T lymphocyte colony formation. J Clin Invest 80:772–777
Author information
Authors and Affiliations
Additional information
Supported in part by Asahi Chemical Industry Co., Inc. and by USPHS Grants CA-24538, CA-15142 and CA-09072 awarded by the National Cancer Institute, Department of Health and Human Services
Rights and permissions
About this article
Cite this article
Ehrke, M.J., Ho, R.L.X. & Hori, K. Species-specific TNF induction of thymocyte proliferation. Cancer Immunol Immunother 27, 103–108 (1988). https://doi.org/10.1007/BF00200012
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00200012